APO Research
Talk to an analyst

APO RESEARCH · REPORT

Scopolamine

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.

Selected research

Market Analysis & Forecast

Global Scopolamine Market Analysis and Forecast 2026-2032

1 January 2026191 pages

Choose your research edition.

Industry ResearchScopolamine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Scopolamine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Scopolamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Scopolamine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Scopolamine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.

The major players in global Scopolamine market include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, etc. The top 3 players occupy about 55% shares of the global market. Australia and Europe are main markets, they occupy about 60% of the global market. Scopolamine Hydrobromide is the main type, with a share about 45%. Patches is the main application, which holds a share about 60%.

This report presents an overview of global market for Scopolamine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Scopolamine, also provides the sales of main regions and countries. Of the upcoming market potential for Scopolamine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Scopolamine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Scopolamine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Scopolamine sales, projected growth trends, production technology, application and end-user industry.

Scopolamine Segment by Company

Alkaloids of Australia

Boehringer Ingelheim

Fine Chemicals Corporation

Phytex Australia

Alchem International

Guangzhou Hanfang

Alkaloids Corporation

Luyin

Scopolamine Segment by Type

Scopolamine Butylbromide

Scopolamine Hydrobromide

Others

Scopolamine Segment by Application

Tablets

Injection

Patches

Scopolamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Scopolamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Scopolamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Scopolamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Scopolamine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Scopolamine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Scopolamine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Scopolamine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Scopolamine Butylbromide Major Manufacturers Table 3. Scopolamine Hydrobromide Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Scopolamine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Tablets Major Manufacturers Table 7. Injection Major Manufacturers Table 8. Patches Major Manufacturers Table 9. Scopolamine Industry Trends Table 10. Scopolamine Industry Drivers Table 11. Scopolamine Industry Opportunities and Challenges Table 12. Scopolamine Industry Restraints Table 13. Global Scopolamine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Scopolamine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Scopolamine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Scopolamine Revenue Market Share by Region (2021-2026) Table 17. Global Scopolamine Revenue Market Share by Region (2027-2032) Table 18. Global Scopolamine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 19. Global Scopolamine Sales by Region (2021-2026) & (Kg) Table 20. Global Scopolamine Sales by Region (2027-2032) & (Kg) Table 21. Global Scopolamine Sales Market Share by Region (2021-2026) Table 22. Global Scopolamine Sales Market Share by Region (2027-2032) Table 23. Global Scopolamine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Scopolamine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Scopolamine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Scopolamine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Scopolamine Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 28. Global Scopolamine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Scopolamine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Scopolamine Manufacturers, Product Type & Application Table 31. Global Scopolamine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Scopolamine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Scopolamine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Scopolamine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Scopolamine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Scopolamine Revenue Market Share by Type (2021-2026) Table 38. Global Scopolamine Revenue Market Share by Type (2027-2032) Table 39. Global Scopolamine Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 40. Global Scopolamine Sales by Type (2021-2026) & (Kg) Table 41. Global Scopolamine Sales by Type (2027-2032) & (Kg) Table 42. Global Scopolamine Sales Market Share by Type (2021-2026) Table 43. Global Scopolamine Sales Market Share by Type (2027-2032) Table 44. Global Scopolamine Price by Type (2021-2026) & (US$/Kg) Table 45. Global Scopolamine Price by Type (2027-2032) & (US$/Kg) Table 46. Global Scopolamine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Scopolamine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Scopolamine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Scopolamine Revenue Market Share by Application (2021-2026) Table 50. Global Scopolamine Revenue Market Share by Application (2027-2032) Table 51. Global Scopolamine Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 52. Global Scopolamine Sales by Application (2021-2026) & (Kg) Table 53. Global Scopolamine Sales by Application (2027-2032) & (Kg) Table 54. Global Scopolamine Sales Market Share by Application (2021-2026) Table 55. Global Scopolamine Sales Market Share by Application (2027-2032) Table 56. Global Scopolamine Price by Application (2021-2026) & (US$/Kg) Table 57. Global Scopolamine Price by Application (2027-2032) & (US$/Kg) Table 58. Alkaloids of Australia Company Information Table 59. Alkaloids of Australia Business Overview Table 60. Alkaloids of Australia Scopolamine Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 61. Alkaloids of Australia Scopolamine Product Portfolio Table 62. Alkaloids of Australia Recent Development Table 63. Boehringer Ingelheim Company Information Table 64. Boehringer Ingelheim Business Overview Table 65. Boehringer Ingelheim Scopolamine Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 66. Boehringer Ingelheim Scopolamine Product Portfolio Table 67. Boehringer Ingelheim Recent Development Table 68. Fine Chemicals Corporation Company Information Table 69. Fine Chemicals Corporation Business Overview Table 70. Fine Chemicals Corporation Scopolamine Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Fine Chemicals Corporation Scopolamine Product Portfolio Table 72. Fine Chemicals Corporation Recent Development Table 73. Phytex Australia Company Information Table 74. Phytex Australia Business Overview Table 75. Phytex Australia Scopolamine Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. Phytex Australia Scopolamine Product Portfolio Table 77. Phytex Australia Recent Development Table 78. Alchem International Company Information Table 79. Alchem International Business Overview Table 80. Alchem International Scopolamine Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Alchem International Scopolamine Product Portfolio Table 82. Alchem International Recent Development Table 83. Guangzhou Hanfang Company Information Table 84. Guangzhou Hanfang Business Overview Table 85. Guangzhou Hanfang Scopolamine Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. Guangzhou Hanfang Scopolamine Product Portfolio Table 87. Guangzhou Hanfang Recent Development Table 88. Alkaloids Corporation Company Information Table 89. Alkaloids Corporation Business Overview Table 90. Alkaloids Corporation Scopolamine Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Alkaloids Corporation Scopolamine Product Portfolio Table 92. Alkaloids Corporation Recent Development Table 93. Luyin Company Information Table 94. Luyin Business Overview Table 95. Luyin Scopolamine Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. Luyin Scopolamine Product Portfolio Table 97. Luyin Recent Development Table 98. North America Scopolamine Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Scopolamine Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Scopolamine Sales by Type (2021-2026) & (Kg) Table 101. North America Scopolamine Sales by Type (2027-2032) & (Kg) Table 102. North America Scopolamine Sales Price by Type (2021-2026) & (US$/Kg) Table 103. North America Scopolamine Sales Price by Type (2027-2032) & (US$/Kg) Table 104. North America Scopolamine Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Scopolamine Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Scopolamine Sales by Application (2021-2026) & (Kg) Table 107. North America Scopolamine Sales by Application (2027-2032) & (Kg) Table 108. North America Scopolamine Sales Price by Application (2021-2026) & (US$/Kg) Table 109. North America Scopolamine Sales Price by Application (2027-2032) & (US$/Kg) Table 110. North America Scopolamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Scopolamine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Scopolamine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Scopolamine Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 114. North America Scopolamine Sales by Country (2021-2026) & (Kg) Table 115. North America Scopolamine Sales by Country (2027-2032) & (Kg) Table 116. North America Scopolamine Sales Price by Country (2021-2026) & (US$/Kg) Table 117. North America Scopolamine Sales Price by Country (2027-2032) & (US$/Kg) Table 118. United States Scopolamine Revenue (2021-2032) & (US$ Million) Table 119. Canada Scopolamine Revenue (2021-2032) & (US$ Million) Table 120. Mexico Scopolamine Revenue (2021-2032) & (US$ Million) Table 121. Europe Scopolamine Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Scopolamine Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Scopolamine Sales by Type (2021-2026) & (Kg) Table 124. Europe Scopolamine Sales by Type (2027-2032) & (Kg) Table 125. Europe Scopolamine Sales Price by Type (2021-2026) & (US$/Kg) Table 126. Europe Scopolamine Sales Price by Type (2027-2032) & (US$/Kg) Table 127. Europe Scopolamine Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Scopolamine Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Scopolamine Sales by Application (2021-2026) & (Kg) Table 130. Europe Scopolamine Sales by Application (2027-2032) & (Kg) Table 131. Europe Scopolamine Sales Price by Application (2021-2026) & (US$/Kg) Table 132. Europe Scopolamine Sales Price by Application (2027-2032) & (US$/Kg) Table 133. Europe Scopolamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Scopolamine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Scopolamine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Scopolamine Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 137. Europe Scopolamine Sales by Country (2021-2026) & (Kg) Table 138. Europe Scopolamine Sales by Country (2027-2032) & (Kg) Table 139. Europe Scopolamine Sales Price by Country (2021-2026) & (US$/Kg) Table 140. Europe Scopolamine Sales Price by Country (2027-2032) & (US$/Kg) Table 141. Germany Scopolamine Revenue (2021-2032) & (US$ Million) Table 142. France Scopolamine Revenue (2021-2032) & (US$ Million) Table 143. U.K. Scopolamine Revenue (2021-2032) & (US$ Million) Table 144. Italy Scopolamine Revenue (2021-2032) & (US$ Million) Table 145. Russia Scopolamine Revenue (2021-2032) & (US$ Million) Table 146. Spain Scopolamine Revenue (2021-2032) & (US$ Million) Table 147. Netherlands Scopolamine Revenue (2021-2032) & (US$ Million) Table 148. Switzerland Scopolamine Revenue (2021-2032) & (US$ Million) Table 149. Sweden Scopolamine Revenue (2021-2032) & (US$ Million) Table 150. Poland Scopolamine Revenue (2021-2032) & (US$ Million) Table 151. China Scopolamine Revenue by Type (2021-2026) & (US$ Million) Table 152. China Scopolamine Revenue by Type (2027-2032) & (US$ Million) Table 153. China Scopolamine Sales by Type (2021-2026) & (Kg) Table 154. China Scopolamine Sales by Type (2027-2032) & (Kg) Table 155. China Scopolamine Sales Price by Type (2021-2026) & (US$/Kg) Table 156. China Scopolamine Sales Price by Type (2027-2032) & (US$/Kg) Table 157. China Scopolamine Revenue by Application (2021-2026) & (US$ Million) Table 158. China Scopolamine Revenue by Application (2027-2032) & (US$ Million) Table 159. China Scopolamine Sales by Application (2021-2026) & (Kg) Table 160. China Scopolamine Sales by Application (2027-2032) & (Kg) Table 161. China Scopolamine Sales Price by Application (2021-2026) & (US$/Kg) Table 162. China Scopolamine Sales Price by Application (2027-2032) & (US$/Kg) Table 163. Asia Scopolamine Revenue by Type (2021-2026) & (US$ Million) Table 164. Asia Scopolamine Revenue by Type (2027-2032) & (US$ Million) Table 165. Asia Scopolamine Sales by Type (2021-2026) & (Kg) Table 166. Asia Scopolamine Sales by Type (2027-2032) & (Kg) Table 167. Asia Scopolamine Sales Price by Type (2021-2026) & (US$/Kg) Table 168. Asia Scopolamine Sales Price by Type (2027-2032) & (US$/Kg) Table 169. Asia Scopolamine Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia Scopolamine Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia Scopolamine Sales by Application (2021-2026) & (Kg) Table 172. Asia Scopolamine Sales by Application (2027-2032) & (Kg) Table 173. Asia Scopolamine Sales Price by Application (2021-2026) & (US$/Kg) Table 174. Asia Scopolamine Sales Price by Application (2027-2032) & (US$/Kg) Table 175. Asia Scopolamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Asia Scopolamine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Asia Scopolamine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Asia Scopolamine Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 179. Asia Scopolamine Sales by Country (2021-2026) & (Kg) Table 180. Asia Scopolamine Sales by Country (2027-2032) & (Kg) Table 181. Asia Scopolamine Sales Price by Country (2021-2026) & (US$/Kg) Table 182. Asia Scopolamine Sales Price by Country (2027-2032) & (US$/Kg) Table 183. Japan Scopolamine Revenue (2021-2032) & (US$ Million) Table 184. South Korea Scopolamine Revenue (2021-2032) & (US$ Million) Table 185. India Scopolamine Revenue (2021-2032) & (US$ Million) Table 186. Australia Scopolamine Revenue (2021-2032) & (US$ Million) Table 187. Taiwan Scopolamine Revenue (2021-2032) & (US$ Million) Table 188. Southeast Asia Scopolamine Revenue (2021-2032) & (US$ Million) Table 189. SAMEA Scopolamine Revenue by Type (2021-2026) & (US$ Million) Table 190. SAMEA Scopolamine Revenue by Type (2027-2032) & (US$ Million) Table 191. SAMEA Scopolamine Sales by Type (2021-2026) & (Kg) Table 192. SAMEA Scopolamine Sales by Type (2027-2032) & (Kg) Table 193. SAMEA Scopolamine Sales Price by Type (2021-2026) & (US$/Kg) Table 194. SAMEA Scopolamine Sales Price by Type (2027-2032) & (US$/Kg) Table 195. SAMEA Scopolamine Revenue by Application (2021-2026) & (US$ Million) Table 196. SAMEA Scopolamine Revenue by Application (2027-2032) & (US$ Million) Table 197. SAMEA Scopolamine Sales by Application (2021-2026) & (Kg) Table 198. SAMEA Scopolamine Sales by Application (2027-2032) & (Kg) Table 199. SAMEA Scopolamine Sales Price by Application (2021-2026) & (US$/Kg) Table 200. SAMEA Scopolamine Sales Price by Application (2027-2032) & (US$/Kg) Table 201. SAMEA Scopolamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. SAMEA Scopolamine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. SAMEA Scopolamine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. SAMEA Scopolamine Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 205. SAMEA Scopolamine Sales by Country (2021-2026) & (Kg) Table 206. SAMEA Scopolamine Sales by Country (2027-2032) & (Kg) Table 207. SAMEA Scopolamine Sales Price by Country (2021-2026) & (US$/Kg) Table 208. SAMEA Scopolamine Sales Price by Country (2027-2032) & (US$/Kg) Table 209. Brazil Scopolamine Revenue (2021-2032) & (US$ Million) Table 210. Argentina Scopolamine Revenue (2021-2032) & (US$ Million) Table 211. Chile Scopolamine Revenue (2021-2032) & (US$ Million) Table 212. Colombia Scopolamine Revenue (2021-2032) & (US$ Million) Table 213. Peru Scopolamine Revenue (2021-2032) & (US$ Million) Table 214. Saudi Arabia Scopolamine Revenue (2021-2032) & (US$ Million) Table 215. Israel Scopolamine Revenue (2021-2032) & (US$ Million) Table 216. UAE Scopolamine Revenue (2021-2032) & (US$ Million) Table 217. Turkey Scopolamine Revenue (2021-2032) & (US$ Million) Table 218. Iran Scopolamine Revenue (2021-2032) & (US$ Million) Table 219. Egypt Scopolamine Revenue (2021-2032) & (US$ Million) Table 220. Key Raw Materials Table 221. Raw Materials Key Suppliers Table 222. Scopolamine Distributors List Table 223. Scopolamine Customers List Table 224. Research Programs/Design for This Report Table 225. Authors List of This Report Table 226. Secondary Sources Table 227. Primary Sources List of Figures Figure 1. Scopolamine Image Figure 2. Global Scopolamine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Scopolamine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Scopolamine Butylbromide Image Figure 5. Scopolamine Hydrobromide Image Figure 6. Others Image Figure 7. Global Scopolamine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Scopolamine Market Size Share 2021 VS 2025 VS 2032 Figure 9. Tablets Image Figure 10. Injection Image Figure 11. Patches Image Figure 12. Global Scopolamine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Scopolamine Revenue (2021-2032) & (US$ Million) Figure 14. Global Scopolamine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Scopolamine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Scopolamine Revenue Market Share by Region (2021-2032) Figure 17. Global Scopolamine Sales (2021-2032) & (Kg) Figure 18. Global Scopolamine Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 19. Global Scopolamine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Scopolamine Sales YoY (2021-2032) & (Kg) Figure 21. Europe Scopolamine Sales YoY (2021-2032) & (Kg) Figure 22. China Scopolamine Sales YoY (2021-2032) & (Kg) Figure 23. Asia (Excluding China) Scopolamine Sales YoY (2021-2032) & (Kg) Figure 24. South America, Middle East and Africa Scopolamine Sales YoY (2021-2032) & (Kg) Figure 25. Global Scopolamine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Scopolamine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Scopolamine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Scopolamine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Scopolamine Revenue Market Share by Type (2021-2032) Figure 31. Global Scopolamine Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 32. Global Scopolamine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Scopolamine Sales Market Share by Type (2021-2032) Figure 34. Global Scopolamine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Scopolamine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Scopolamine Revenue Market Share by Application (2021-2032) Figure 37. Global Scopolamine Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 38. Global Scopolamine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Scopolamine Sales Market Share by Application (2021-2032) Figure 40. North America Scopolamine Revenue Share by Type (2021-2032) Figure 41. North America Scopolamine Sales Share by Type (2021-2032) Figure 42. North America Scopolamine Revenue Share by Application (2021-2032) Figure 43. North America Scopolamine Sales Share by Application (2021-2032) Figure 44. North America Scopolamine Revenue Share by Country (2021-2032) Figure 45. North America Scopolamine Sales Share by Country (2021-2032) Figure 46. Europe Scopolamine Revenue Share by Type (2021-2032) Figure 47. Europe Scopolamine Sales Share by Type (2021-2032) Figure 48. Europe Scopolamine Revenue Share by Application (2021-2032) Figure 49. Europe Scopolamine Sales Share by Application (2021-2032) Figure 50. Europe Scopolamine Revenue Share by Country (2021-2032) Figure 51. Europe Scopolamine Sales Share by Country (2021-2032) Figure 52. China Scopolamine Revenue Share by Type (2021-2032) Figure 53. China Scopolamine Sales Share by Type (2021-2032) Figure 54. China Scopolamine Revenue Share by Application (2021-2032) Figure 55. China Scopolamine Sales Share by Application (2021-2032) Figure 56. Asia Scopolamine Revenue Share by Type (2021-2032) Figure 57. Asia Scopolamine Sales Share by Type (2021-2032) Figure 58. Asia Scopolamine Revenue Share by Application (2021-2032) Figure 59. Asia Scopolamine Sales Share by Application (2021-2032) Figure 60. Asia Scopolamine Revenue Share by Country (2021-2032) Figure 61. Asia Scopolamine Sales Share by Country (2021-2032) Figure 62. SAMEA Scopolamine Revenue Share by Type (2021-2032) Figure 63. SAMEA Scopolamine Sales Share by Type (2021-2032) Figure 64. SAMEA Scopolamine Revenue Share by Application (2021-2032) Figure 65. SAMEA Scopolamine Sales Share by Application (2021-2032) Figure 66. SAMEA Scopolamine Revenue Share by Country (2021-2032) Figure 67. SAMEA Scopolamine Sales Share by Country (2021-2032) Figure 68. Scopolamine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Scopolamine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Scopolamine Butylbromide
  • Scopolamine Hydrobromide
  • Others
Applications
  • Tablets
  • Injection
  • Patches
Companies covered
  • Alkaloids of Australia
  • Boehringer Ingelheim
  • Fine Chemicals Corporation
  • Phytex Australia
  • Alchem International
  • Guangzhou Hanfang
  • Alkaloids Corporation
  • Luyin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Scopolamine Market by Type
  3. 1.2.1 Global Scopolamine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Scopolamine Butylbromide
  5. 1.2.3 Scopolamine Hydrobromide
  6. 1.2.4 Others
  7. 1.3 Scopolamine Market by Application
  8. 1.3.1 Global Scopolamine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Tablets
  10. 1.3.3 Injection
  11. 1.3.4 Patches
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Scopolamine Market Dynamics
  1. 2.1 Scopolamine Industry Trends
  2. 2.2 Scopolamine Industry Drivers
  3. 2.3 Scopolamine Industry Opportunities and Challenges
  4. 2.4 Scopolamine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Scopolamine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Scopolamine Revenue by Region
  3. 3.2.1 Global Scopolamine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Scopolamine Revenue by Region (2021-2026)
  5. 3.2.3 Global Scopolamine Revenue by Region (2027-2032)
  6. 3.2.4 Global Scopolamine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Scopolamine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Scopolamine Sales by Region
  9. 3.4.1 Global Scopolamine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Scopolamine Sales by Region (2021-2026)
  11. 3.4.3 Global Scopolamine Sales by Region (2027-2032)
  12. 3.4.4 Global Scopolamine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Scopolamine Revenue by Manufacturers
  2. 4.1.1 Global Scopolamine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Scopolamine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Scopolamine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Scopolamine Sales by Manufacturers
  6. 4.2.1 Global Scopolamine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Scopolamine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Scopolamine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Scopolamine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Scopolamine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Scopolamine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Scopolamine Manufacturers, Product Type & Application
  13. 4.7 Global Scopolamine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Scopolamine Market CR5 and HHI
  16. 4.8.2 2025 Scopolamine Tier 1, Tier 2, and Tier 3
5 Scopolamine Market by Type
  1. 5.1 Global Scopolamine Revenue by Type
  2. 5.1.1 Global Scopolamine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Scopolamine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Scopolamine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Scopolamine Sales by Type
  6. 5.2.1 Global Scopolamine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Scopolamine Sales by Type (2021-2032) & (Kg)
  8. 5.2.3 Global Scopolamine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Scopolamine Price by Type
6 Scopolamine Market by Application
  1. 6.1 Global Scopolamine Revenue by Application
  2. 6.1.1 Global Scopolamine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Scopolamine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Scopolamine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Scopolamine Sales by Application
  6. 6.2.1 Global Scopolamine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Scopolamine Sales by Application (2021-2032) & (Kg)
  8. 6.2.3 Global Scopolamine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Scopolamine Price by Application
7 Company Profiles
  1. 7.1 Alkaloids of Australia
  2. 7.1.1 Alkaloids of Australia Company Information
  3. 7.1.2 Alkaloids of Australia Business Overview
  4. 7.1.3 Alkaloids of Australia Scopolamine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Alkaloids of Australia Scopolamine Product Portfolio
  6. 7.1.5 Alkaloids of Australia Recent Developments
  7. 7.2 Boehringer Ingelheim
  8. 7.2.1 Boehringer Ingelheim Company Information
  9. 7.2.2 Boehringer Ingelheim Business Overview
  10. 7.2.3 Boehringer Ingelheim Scopolamine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Boehringer Ingelheim Scopolamine Product Portfolio
  12. 7.2.5 Boehringer Ingelheim Recent Developments
  13. 7.3 Fine Chemicals Corporation
  14. 7.3.1 Fine Chemicals Corporation Company Information
  15. 7.3.2 Fine Chemicals Corporation Business Overview
  16. 7.3.3 Fine Chemicals Corporation Scopolamine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Fine Chemicals Corporation Scopolamine Product Portfolio
  18. 7.3.5 Fine Chemicals Corporation Recent Developments
  19. 7.4 Phytex Australia
  20. 7.4.1 Phytex Australia Company Information
  21. 7.4.2 Phytex Australia Business Overview
  22. 7.4.3 Phytex Australia Scopolamine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Phytex Australia Scopolamine Product Portfolio
  24. 7.4.5 Phytex Australia Recent Developments
  25. 7.5 Alchem International
  26. 7.5.1 Alchem International Company Information
  27. 7.5.2 Alchem International Business Overview
  28. 7.5.3 Alchem International Scopolamine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Alchem International Scopolamine Product Portfolio
  30. 7.5.5 Alchem International Recent Developments
  31. 7.6 Guangzhou Hanfang
  32. 7.6.1 Guangzhou Hanfang Company Information
  33. 7.6.2 Guangzhou Hanfang Business Overview
  34. 7.6.3 Guangzhou Hanfang Scopolamine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Guangzhou Hanfang Scopolamine Product Portfolio
  36. 7.6.5 Guangzhou Hanfang Recent Developments
  37. 7.7 Alkaloids Corporation
  38. 7.7.1 Alkaloids Corporation Company Information
  39. 7.7.2 Alkaloids Corporation Business Overview
  40. 7.7.3 Alkaloids Corporation Scopolamine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Alkaloids Corporation Scopolamine Product Portfolio
  42. 7.7.5 Alkaloids Corporation Recent Developments
  43. 7.8 Luyin
  44. 7.8.1 Luyin Company Information
  45. 7.8.2 Luyin Business Overview
  46. 7.8.3 Luyin Scopolamine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Luyin Scopolamine Product Portfolio
  48. 7.8.5 Luyin Recent Developments
8 North America
  1. 8.1 North America Scopolamine Market Size by Type
  2. 8.1.1 North America Scopolamine Revenue by Type (2021-2032)
  3. 8.1.2 North America Scopolamine Sales by Type (2021-2032)
  4. 8.1.3 North America Scopolamine Price by Type (2021-2032)
  5. 8.2 North America Scopolamine Market Size by Application
  6. 8.2.1 North America Scopolamine Revenue by Application (2021-2032)
  7. 8.2.2 North America Scopolamine Sales by Application (2021-2032)
  8. 8.2.3 North America Scopolamine Price by Application (2021-2032)
  9. 8.3 North America Scopolamine Market Size by Country
  10. 8.3.1 North America Scopolamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Scopolamine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Scopolamine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Scopolamine Market Size by Type
  2. 9.1.1 Europe Scopolamine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Scopolamine Sales by Type (2021-2032)
  4. 9.1.3 Europe Scopolamine Price by Type (2021-2032)
  5. 9.2 Europe Scopolamine Market Size by Application
  6. 9.2.1 Europe Scopolamine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Scopolamine Sales by Application (2021-2032)
  8. 9.2.3 Europe Scopolamine Price by Application (2021-2032)
  9. 9.3 Europe Scopolamine Market Size by Country
  10. 9.3.1 Europe Scopolamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Scopolamine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Scopolamine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Scopolamine Market Size by Type
  2. 10.1.1 China Scopolamine Revenue by Type (2021-2032)
  3. 10.1.2 China Scopolamine Sales by Type (2021-2032)
  4. 10.1.3 China Scopolamine Price by Type (2021-2032)
  5. 10.2 China Scopolamine Market Size by Application
  6. 10.2.1 China Scopolamine Revenue by Application (2021-2032)
  7. 10.2.2 China Scopolamine Sales by Application (2021-2032)
  8. 10.2.3 China Scopolamine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Scopolamine Market Size by Type
  2. 11.1.1 Asia Scopolamine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Scopolamine Sales by Type (2021-2032)
  4. 11.1.3 Asia Scopolamine Price by Type (2021-2032)
  5. 11.2 Asia Scopolamine Market Size by Application
  6. 11.2.1 Asia Scopolamine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Scopolamine Sales by Application (2021-2032)
  8. 11.2.3 Asia Scopolamine Price by Application (2021-2032)
  9. 11.3 Asia Scopolamine Market Size by Country
  10. 11.3.1 Asia Scopolamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Scopolamine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Scopolamine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Scopolamine Market Size by Type
  2. 12.1.1 SAMEA Scopolamine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Scopolamine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Scopolamine Price by Type (2021-2032)
  5. 12.2 SAMEA Scopolamine Market Size by Application
  6. 12.2.1 SAMEA Scopolamine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Scopolamine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Scopolamine Price by Application (2021-2032)
  9. 12.3 SAMEA Scopolamine Market Size by Country
  10. 12.3.1 SAMEA Scopolamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Scopolamine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Scopolamine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Scopolamine Value Chain Analysis
  2. 13.1.1 Scopolamine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Scopolamine Production Mode & Process
  6. 13.2 Scopolamine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Scopolamine Distributors
  9. 13.2.3 Scopolamine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst